Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medical Expulsive Therapy for Ureter Stone Using Naftopidil
NCT01952314Phase 3Completed
- Sponsor
- Seoul National University Hospital
- Start
- May 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of naftopidil in ureteral stone, sponsored by Seoul National University Hospital. Started May 2014; status: completed.
02
Drugs
naftopidil
03
Conditions
ureteral stone
Beyond the preview
Go deeper on NCT01952314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01952314.